ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Centessa Pharmaceuticals plc Investors to Inquire About Securities Class Action Investigation – CNTA
NEW YORK, Sept. 03, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Centessa Pharmaceuticals plc (NASDAQ: CNTA) resulting from allegations that Centessa may have issued materially misleading business information to the investing